Tempus AI, Inc. $TEM Shares Purchased by Rakuten Securities Inc.

Rakuten Securities Inc. increased its stake in Tempus AI, Inc. (NASDAQ:TEM) by 91.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,793 shares of the company’s stock after acquiring an additional 10,879 shares during the quarter. Rakuten Securities Inc.’s holdings in Tempus AI were worth $1,840,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Royal Bank of Canada increased its stake in Tempus AI by 201.2% during the 1st quarter. Royal Bank of Canada now owns 25,988 shares of the company’s stock worth $1,253,000 after buying an additional 17,359 shares in the last quarter. Strs Ohio purchased a new stake in shares of Tempus AI during the first quarter worth approximately $1,718,000. Rhumbline Advisers purchased a new stake in shares of Tempus AI during the first quarter worth approximately $116,000. Voya Investment Management LLC acquired a new position in Tempus AI in the 1st quarter valued at $1,717,000. Finally, Balefire LLC purchased a new position in Tempus AI in the 2nd quarter valued at $870,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on TEM. HC Wainwright lowered their price target on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Piper Sandler dropped their price target on Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Guggenheim upped their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 26th. Morgan Stanley raised their target price on Tempus AI from $80.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, December 1st. Finally, JPMorgan Chase & Co. lowered their target price on shares of Tempus AI from $85.00 to $80.00 and set a “neutral” rating for the company in a research note on Monday, December 15th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of “Hold” and a consensus target price of $87.20.

Insider Activity at Tempus AI

In related news, CFO James William Rogers sold 19,966 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $73.20, for a total transaction of $1,461,511.20. Following the completion of the transaction, the chief financial officer owned 111,250 shares in the company, valued at approximately $8,143,500. The trade was a 15.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erik Phelps sold 1,302 shares of Tempus AI stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $67.42, for a total value of $87,780.84. Following the sale, the executive vice president directly owned 89,280 shares of the company’s stock, valued at $6,019,257.60. This trade represents a 1.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 932,832 shares of company stock worth $71,184,024 over the last quarter. 26.27% of the stock is currently owned by insiders.

Tempus AI Price Performance

TEM opened at $69.28 on Thursday. The stock’s 50-day moving average price is $69.26 and its 200 day moving average price is $73.40. Tempus AI, Inc. has a 12-month low of $32.90 and a 12-month high of $104.32. The firm has a market cap of $12.33 billion, a price-to-earnings ratio of -58.22 and a beta of 5.22. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The company had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. During the same period in the prior year, the firm earned ($0.46) earnings per share. The business’s revenue for the quarter was up 84.7% compared to the same quarter last year. As a group, sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.